Rajan P Kulkarni

14PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsLiquid biopsiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 03, 2025
The impact of concomitant medications on treatment outcomes in patients with cancer receiving immune checkpoint inhibitors.

Samantha Stone, Jordan P McPherson, Rajan P Kulkarni

|Mar 13, 2025
Personalization of Cancer Treatment: Exploring the Role of Chronotherapy in Immune Checkpoint Inhibitor Efficacy.

Rosalyn M Fey, Avery Billo, Terri Clister

|May 11, 2024
MIF and CD74 as Emerging Biomarkers for Immune Checkpoint Blockade Therapy.

Rosalyn M Fey, Rebecca A Nichols, Thuy T Tran

|Mar 13, 2024
Comparison of Immunotherapy versus Targeted Therapy Effectiveness in BRAF-Mutant Melanoma Patients and Use of cGAS Expression and Aneuploidy as Potential Prognostic Biomarkers.

Zachary Garrison, Terri Clister, Eric Bleem

|Feb 09, 2024
Optimization of Tissue Digestion Methods for Characterization of Photoaged Skin by Single Cell RNA Sequencing Reveals Preferential Enrichment of T Cell Subsets.

Terri Clister, Rosalyn M Fey, Zachary R Garrison

|Oct 18, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0.

Anna C Pavlick, Charlotte E Ariyan, Elizabeth I Buchbinder

Pageof 3

Frequent Collaborators

5 joint publications

Zachary R Garrison

4 joint publications

Rosalyn M Fey

3 joint publications

Terri Clister

2 joint publications

Elizabeth G Berry